DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Premarin (Conjugated Estrogens) - Adverse Event Reports - Life Threatening Events - Metastases TO Lung

 



Index of reports > Cases resulting in life threatening events (5) > Cases with Metastases TO Lung (2)

Below is the selection of adverse event reports related to Premarin (Conjugated Estrogens) that includes cases resulting in life threatening events where reactions include metastases to lung.

Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-24

Patient: female

Adverse reactions / side effects: Endometrial Neoplasm, Metastases TO Lung

Adverse event resulted in: life threatening event

Suspect drug(s):
Premarin
    Dosage: 625ug, frequency unknown
    Administration route: Oral
    Indication: Uterine Leiomyoma
    Start date: 1992-06-01
    End date: 1995-01-01

Premarin
    Dosage: 125ug, frequency unknown
    Administration route: Oral
    Indication: Endometriosis
    Start date: 1995-01-01
    End date: 2004-02-01



Adverse event in female receiving Premarin (Conjugated Estrogens)

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-10-18

Patient: female

Adverse reactions / side effects: Endometrial Neoplasm, Metastases TO Lung

Adverse event resulted in: life threatening event

Suspect drug(s):
Premarin
    Dosage: 625ug, frequency unknown
    Administration route: Oral
    Indication: Uterine Leiomyoma
    Start date: 1992-06-01
    End date: 1995-01-01

Premarin
    Dosage: 125ug, frequency unknown
    Administration route: Oral
    Indication: Endometriosis
    Start date: 1995-01-01
    End date: 2004-02-01

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009